Figure 6From: Systems biology analysis reveals NFAT5 as a novel biomarker and master regulator of inflammatory breast cancerMGA and NFAT5-target genes expression in the TMA validation series. A: Percentage of tumor specimens expressing MGA and NFAT5-target genes (COX2 and S100A4) in the TMA validation series of IBC and nIBC subtypes. The p-values reported in graph were obtained by chi-square test with Yates’s correction for continuity between IBC and nIBC groups. B: COX2, MGA and S100A4 immunopositivity in representative cases of IBC.Back to article page